Sub-chronic toxicity of an aqueous extract of Epimedium sagittatum (Sieb. Et Zucc.) Maxim. in rats

References

• Bando, K., et al., 2011. GC-MS-based metabolomics reveals mechanism of action for hydrazine induced hepatotoxicity in rats. Journal of Applied Toxicology, 31 (6), 524–535.
   PubMed Web of Science ®Google Scholar
• Cha, S.B., et al., 2021. A 13-week subchronic toxicity study of a Dioscorea Rhizome water extract in rats. Regulatory Toxicology and Pharmacology, 120, 104844.
   PubMed Web of Science ®Google Scholar
• Chen, X.J., et al., 2008a. A rapid method for simultaneous determination of 15 flavonoids in Epimedium using pressurized liquid extraction and ultra-performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis, 46 (2), 226–235.
   PubMed Web of Science ®Google Scholar
• Chen, X.J., et al., 2008b. Simultaneous determination of seven flavonoids in Epimedium using pressurized liquid extraction and capillary electrochromatography. Journal of Separation Science, 31 (5), 881–887.
   PubMed Web of Science ®Google Scholar
• Chong, J., Wishart, D.S., and Xia, J., 2019. Using Metabo analyst 4.0 for comprehensive and integrative metabolomics data analysis. Current Protocols in Bioinformatics, 68 (1), e86.
   PubMedGoogle Scholar
• Dunn, W.B., et al., 2011. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nature Protocols, 6 (7), 1060–1083.
   PubMed Web of Science ®Google Scholar
• Giannini, E.G., Testa, R., and Savarino, V., 2005. Liver enzyme alteration: a guide for clinicians. CMAJ: Canadian Medical Association Journal, 172 (3), 367–379.
   PubMed Web of Science ®Google Scholar
• Gorman, L.S., 2013. The adrenal gland: common disease states and suspected new applications. Clinical Laboratory Science, 26 (2), 118–125.
   PubMedGoogle Scholar
• Gray, L.R., Tompkins, S.C., and Taylor, E.B., 2014. Regulation of pyruvate metabolism and human disease. Cellular and Molecular Life Sciences, 71 (14), 2577–2604.
   PubMed Web of Science ®Google Scholar
• Guan, X.Y., et al., 2011. HPLC-DAD-MS(n) analysis and HPLC quantitation of chemical constituents in Xian-ling-gu-bao capsules. Journal of Pharmaceutical and Biomedical Analysis, 55 (5), 923–933.
   PubMed Web of Science ®Google Scholar
• He, Q. and Tan, H.B., 2015. Liver damage occurred in one HBV carrier caused by Epimedium. Chinese Journal of Liver Diseases, 7 (1), 113–114.
   Google Scholar
• Huo, T., et al., 2016. 1HNMR-based metabonomic study of sub-chronic hepatotoxicity induced by realgar. Journal of Ethnopharmacology, 192, 1–9.
   PubMed Web of Science ®Google Scholar
• Kato, R. and Yamazoe, Y., 1992. Sex-specific cytochrome P450 as a cause of sex- and species-related differences in drug toxicity. Toxicology Letters, 64–65, 661–667.
   PubMed Web of Science ®Google Scholar
• Kawaguchi, T., et al., 2011. Branched-chain amino acids as pharmacological nutrients in chronic liver disease. Hepatology, 54 (3), 1063–1070.
   PubMed Web of Science ®Google Scholar
• Kim, J.H., et al., 2002. Effects of the aqueous extract of Epimedii Herba on the induction of oral tolerance in mice. Biological & Pharmaceutical Bulletin, 25 (8), 1000–1005.
   PubMed Web of Science ®Google Scholar
• Kisui, F., et al., 2020. Strain and sex differences in drug hydrolase activities in rodent livers. European Journal of Pharmaceutical Sciences, 142, 105143.
   PubMed Web of Science ®Google Scholar
• Li, B.Q., et al., 2010. Role of chlorogenic acid in the toxicity induced by Chinese herbal injections. Drug and Chemical Toxicology, 33 (4), 415–420.
   PubMed Web of Science ®Google Scholar
• Liu, C., et al., 2016. Research advances on hepatotoxicity of herbal medicines in China. BioMed Research International, 2016, 7150391.
   PubMed Web of Science ®Google Scholar
• Ma, A., et al., 2004. Baohuoside-1, a novel immunosuppressive molecule, inhibits lymphocyte activation in vitro and in vivo. Transplantation, 78 (6), 831–838.
   PubMed Web of Science ®Google Scholar
• Ma, H., et al., 2011. The genus Epimedium: an ethnopharmacological and phytochemical review. Journal of Ethnopharmacology, 134 (3), 519–541.
   PubMed Web of Science ®Google Scholar
• Mitrega, K., et al., 2011. Beneficial effects of l-leucine and l-valine on arrhythmias, hemodynamics and myocardial morphology in rats. Pharmacological Research, 64 (3), 218–225.
   PubMed Web of Science ®Google Scholar
• Mori, A., et al., 2009. Clinical significance of plasma mannose concentrations in healthy and diabetic dogs. Veterinary Research Communications, 33 (5), 439–451.
   PubMed Web of Science ®Google Scholar
• National Commission of Chinese Pharmacopoeia. 2020. Chinese pharmacopoeia. Beijing, China: China Medical Science Press.
   Google Scholar
• National Medical Products Administration of China. 2008. ADR information communication (Issue 16). Beijing, China: National Medical Products Administration of China. Available from: http://www.nmpa.gov.cn/WS04/CL2155/318831.html [Accessed 9 August 2008].
   Google Scholar
• Pang, X., et al., 2018. Prenylated flavonoids and dihydrophenanthrenes from the leaves of Epimedium brevicornu and their cytotoxicity against HepG2 cells. Natural Product Research, 32 (19), 2253–2259.
   PubMed Web of Science ®Google Scholar
• Sharma, V., Ichikawa, M., and Freeze, H.H., 2014. Mannose metabolism: more than meets the eye. Biochemical and Biophysical Research Communications, 453 (2), 220–228.
   PubMed Web of Science ®Google Scholar
• Shen, P., et al., 2009. Simple and sensitive liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of five Epimedium prenylflavonoids in rat sera. Journal of Chromatography B, 877 (1–2), 71–78.
   PubMed Web of Science ®Google Scholar
• Shi, C., et al., 2020. Targeted metabolomics identifies differential serum and liver amino acids biomarkers in rats with alcoholic liver disease. Journal of Nutritional Science and Vitaminology, 66 (6), 536–544.
   PubMed Web of Science ®Google Scholar
• Teo, Y.L., et al., 2019. Pharmacokinetics of prenylflavonoids following oral ingestion of standardized epimedium extract in humans. Planta Medica, 85 (4), 347–355.
   PubMed Web of Science ®Google Scholar
• von Morze, C., et al., 2017. Detection of localized changes in the metabolism of hyperpolarized gluconeogenic precursors 13 C-lactate and 13 C-pyruvate in kidney and liver. Magnetic Resonance in Medicine, 77 (4), 1429–1437.
   PubMed Web of Science ®Google Scholar
• Wang, Q., et al., 2018. Long-term toxicity of different extracts of Epimedium Brevicornu Maxim in mice. Chinese Journal of Pharmacovigilance, 15 (2), 65–69.
   Google Scholar
• Wen, Y., et al., 2020. Sex differences in kidney function and metabolism assessed using hyperpolarized [1-13C] pyruvate interleaved spectroscopy and nonspecific imaging. Tomography (Ann Arbor, MI), 6 (1), 5–13.
   PubMed Web of Science ®Google Scholar
• Westphal, V., et al., 2001. Genetic and metabolic analysis of the first adult with congenital disorder of glycosylation type Ib: long-term outcome and effects of mannose supplementation. Molecular Genetics and Metabolism, 73 (1), 77–85.
   PubMed Web of Science ®Google Scholar
• Xie, L.P., et al., 2004. Amino acids protects against renal ischemia-reperfusion injury and attenuates renal endothelin-1 disorder in rats. Chinese Journal of Traumatology, 7 (2), 87–90.
   PubMedGoogle Scholar
• Xiong, R., et al., 2014. Comparative study on the effect of the crude and mutton-fat-processedEpimedii Folium in Er’xian Decoction on nourishing and warming kidney-yang. Asia-Pacific Traditional Medicine, 10 (22), 5–7.
   Google Scholar
• Xiong, Y., Wu, J.R., and Zhang, C.L., 2019. Research progress of liver injury induced by zhuanggu gangwan pills. Zhongnan Pharmacology, 17 (12), 2084–2087.
   Google Scholar
• Xu, T., et al., 2020b. Magnoflorine: a review of its pharmacology, pharmacokinetics and toxicity. Pharmacological Research, 152, 104632.
   PubMed Web of Science ®Google Scholar
• Xu, Y.Q., et al., 2020a. Distribution of epimedium sagittatum and its research progress on quality characteristics. ChineseTraditional and Herbal Drug, 51 (23), 6119–6132.
   Google Scholar
• Zhang, H.R., et al., 2020b. Flavonoids from the leaves of Epimedium Koreanum Nakai and their potential cytotoxic activities. Natural Product Research, 34 (9), 1256–1263.
   PubMed Web of Science ®Google Scholar
• Zhang, L., et al., 2019a. Effect of 2''-O-rhamnosyl icariside II, baohuoside I and baohuoside II in herba epimedii on cytotoxicity indices in HL-7702 and HepG2 cells. Molecules, 24 (7), 1263.
   PubMed Web of Science ®Google Scholar
• Zhang, L., et al., 2020a. In vitro screening and toxic mechanism exploring of leading components with potential hepatotoxicity of Herba Epimedii extracts. Toxicology in Vitro: An International Journal Published in Association with BIBRA, 62, 104660.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., et al., 2019b. Isopsoralen induces different subchronic toxicities and metabolomic outcomes between male and female Wistar rats. Regulatory Toxicology and Pharmacology: RTP, 103, 1–9.
   PubMed Web of Science ®Google Scholar
• Zhong, R.L., et al., 2019. The toxicity and metabolism properties of herba epimedii flavonoids on laval and adult zebrafish. Evidence-Based Complementary and Alternative Medicine: eCAM, 2019, 3745051.
   PubMed Web of Science ®Google Scholar
• Zhu, C.M., et al., 2018. Liver damage caused by xian-ling gu-bao capsule. Liver, 23 (12), 1090–1093.
   Google Scholar